BH8-23656-54076 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-12
Dose 1 — Janssen/Johnson & Johnson
2021-12-01
Registered in v-safe
2021-12-01
Dose 2 — Moderna
2021-12-01
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-06
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Itching · None

Adult check-in
2021-12-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-12-08
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-12-15
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-12-22
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-12-29
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2022-01-05
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2022-01-12
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2022-03-02
Survey response — 3 months, dose 2
MedDRA: COVID-19, Cough, Pain, Sinus disorder — Feeling: Good

Free text: Aches, sinus issues, cough, COVID

MedDRA releases: 2024-11 · check-in free text available
2022-06-01
Survey response — 6 months, dose 2
MedDRA: Bronchitis, COVID-19, Conjunctivitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: COVID, bronchitis, conjunctivitis

MedDRA releases: 2024-11 · check-in free text available
2022-06-01
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-06-02
Call successful
Does not wish to fill out VAERS report
2022-12-01
Survey response — 12 months, dose 2
MedDRA: Exostosis, Influenza, Nasopharyngitis, Pain in extremity — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Pain/possible bunion/spur in my foot 5th metatarsal Cold/flu

MedDRA releases: 2024-11 · check-in free text available
2022-12-01
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-02
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-12	Janssen/Johnson & Johnson	No
2	2021-12-01	Moderna	No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 11 — 3 months, dose 2

2022-03-02

Symptoms: Aches, sinus issues, cough, COVID

Release 11 — 6 months, dose 2

2022-06-01

Symptoms: COVID, bronchitis, conjunctivitis

Release 12 — 12 months, dose 2

2022-12-01

Symptoms: Pain/possible bunion/spur in my foot 5th metatarsal Cold/flu

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bronchitis	·	·	✓
SD	Conjunctivitis	·	·	✓
SD	Cough	·	·	✓
SD	COVID-19	·	·	✓
SD	Exostosis	·	·	✓
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pain	·	·	✓
SD	Pain in extremity	·	·	✓
SD	Sinus disorder	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release